Therapeutic Neovascularization – Quo vadis?

Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease.- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis.- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction.- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword.- Pampering and Priming the Heart.- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization.- Integrative Pro-angiogenic Activation: HIF-?.- The Maturation of Vessels – A Limitation to Forced Neovascularization?.- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads.- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis.- The Biology of Embryonic and Adult Endothelial Progenitor Cells.- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin.- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.